Final Programme - iuphar

FC13 Maximising benefits and minimising harms from
drugs
Organized by the British Pharmacological Society
Leaders: Munir Pirmohamed, (UK) & Brian Kevin Park, (UK)
FC13.3 Pharmacogenomics and adverse drug reactions
Chairs: Steven J Leeder, (USA) & Munir Pirmohamed, (UK)
09:30 - 09:55 FC13.3.1 The pharmacogenetics of drug hypersensitivity
Simon Mallal, (Australia)
09:55 - 10:20 FC13.3.2 Genetic predisposition to drug-induced liver toxicity
Ann K Daly, (UK)
10:20 - 10:45 FC13.3.3 Developmental considerations for severe adverse drug reactions in children
Steven J Leeder, (USA)
10:45 - 11:15 COFFEE BREAK
11:15 - 11:40 FC13.3.4 Variability in response to anticoagulants
Munir Pirmohamed, (UK)
11:40 - 11:55 FC13.3.5 Free Communication Presentation:
Pharmacokinetic (PK) modeling of factor V activity accurately predicts factor V levels
after treatment with fresh frozen plasma
Kathleen Neville, (USA), G Kearns, J Daniel, W Andrews, B Wicklund
11:55 - 12:10 FC13.3.6 Free Communication Presentation:
Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated
chronic heart failure patients
Morten Petersen, (Denmark), J Andersen, K Broedbaek, B Hjelvang, S Afzal,
M Nyegaard, A Børglum, S Stender, L Køber, C Torp-Pedersen, H Poulsen
124 Thursday 22 July ■ 09:30 - 12:15 ■ Hall A2